Company

AM Biotech scientists are aptamer experts with decades of experience working with nucleic acids in general and aptamers in particular. The company not only provides unique services and products to customers but also is actively involved in research to improve aptamer performance. Our scientists continue to publish in respected journals such as Nature and Nucleic Acid Research; not only about aptamer markets and technology reviews, but on significant advances in understanding aptamer technology and performance.

X-Aptamers are a result of novel research performed by AM Biotech’s scientists. X-Aptamers are short strands of chemically modified nucleic acids that bind to targets with high affinity and specificity. Unlike aptamers or antibodies, discovering X-Aptamers is fast and easy enabling a unique kit for X-Aptamer development. AM Biotech’s mission is to lower the barriers for new users to try synthetic affinity reagents. One of the major barriers is the lack of available synthetic affinity molecules that new users can purchase from a catalog. Another significant barrier is the high cost to develop synthetic affinity agents.

AM Biotech has eliminated the cost barrier using a unique, Co-Development option. Customers purchase our inexpensive kit and complete the protocol using several targets of their choice. AM Biotech will process the sample that results from the kit and deliver several X-Aptamers to test for no charge in exchange for a non-exclusive license to sell the X-Aptamers. Customers benefit from fast, affordable development of excellent synthetic affinity molecules of interest to them. AM Biotech benefits by monetizing the X-Aptamers through an ecommerce catalog. Customers are completely free to commercialize the X-Aptamers they developed and even have the potential to earn a royalty from AM Biotech on catalog sales of X-Aptamers that they developed using the kit.

AM Biotech also offers a turnkey service for selecting X-Aptamers to customer provided targets and will improve existing aptamers (and siRNA) using unique chemical modifications. Reagents used to synthesize some of the unique chemical modifications can be purchased through AM Biotech.

The company is in Houston, Texas near the Texas Medical Center. It has been in operation since 2006, developing chemically modified aptamers using a version of a combinatorial chemistry technology originally developed at the University of Texas Medical Branch in Galveston, Texas.

AM Biotech Customers Include:

  • Major pharmaceutical companies (US and Europe)
  • Biotechnology companies (US and Europe)
  • Universities (US and Canada)
  • The National Institutes of Health (NIH)
  • The National Aeronautics and Space Administration (NASA)
  • The UK Defence Science & Technology Laboratory (DSTL)

X-Aptamer Selection Kit Distributors:

  • Japan – Funakoshi
  • South Korea – Sambo

The following entities have generously provided support for research:

  • The National Institutes of Health (NIH)
  • The National Aeronautics and Space Administration (NASA)
  • Defense Advanced Research Projects Agency (DARPA)
  • The Bill & Melinda Gates Foundation

World Map of AM Biotech Customers and Distributors: